Skip to main
UHS

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 11 analyst ratings
Hold
Strong Buy 27%
Buy 9%
Hold 55%
Sell 9%
Strong Sell 0%

Bulls say

Universal Health Services is positioned for growth with its strong presence in the US healthcare market and a solid financial performance. The recent decline in share value due to investor concerns over the company's ability to achieve core growth acceleration signifies a buying opportunity as the company has consistently maintained its earnings outlook. With a diversified portfolio of services and a focus on expanding into outpatient facilities, UHS is well-equipped to weather any potential challenges in the industry and continue its profitable growth trajectory.

Bears say

Universal Health Services is facing multiple challenges that are likely to impact its growth and margins, such as the reimbursement environment for Medicaid and a potential decline in volume due to regulatory and media scrutiny. Additionally, the company's high concentration in the Las Vegas market and reliance on tight state budgets for its behavioral health business also pose significant risks. While management remains confident in its ability to accelerate growth in the second half of 2025, execution risks and a challenging industry backdrop warrant a lower target multiple for the stock.

UHS has been analyzed by 11 analysts, with a consensus rating of Hold. 27% of analysts recommend a Strong Buy, 9% recommend Buy, 55% suggest Holding, 9% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Hold based on their latest research and market trends.

According to 11 analysts, UHS has a Hold consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $209.82, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $209.82, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.